Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.28p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 212,860
  • Market Cap: £5.91m

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
57.83% below the market average57.83% below the market average57.83% below the market average57.83% below the market average57.83% below the market average
72.41% below the sector average72.41% below the sector average72.41% below the sector average72.41% below the sector average72.41% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
50.00% above the market average50.00% above the market average50.00% above the market average50.00% above the market average50.00% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Price Book Ratio
54.29% below the market average54.29% below the market average54.29% below the market average54.29% below the market average54.29% below the market average
2.56% above the sector average2.56% above the sector average2.56% above the sector average2.56% above the sector average2.56% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
81.90% above the market average81.90% above the market average81.90% above the market average81.90% above the market average81.90% above the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Chg 3m
0.39% below the market average0.39% below the market average0.39% below the market average0.39% below the market average0.39% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
97.08% above the market average97.08% above the market average97.08% above the market average97.08% above the market average97.08% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Momentum 20
27.94% below the market average27.94% below the market average27.94% below the market average27.94% below the market average27.94% below the market average
9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
91.49% below the market average91.49% below the market average91.49% below the market average91.49% below the market average91.49% below the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
56.56% below the market average56.56% below the market average56.56% below the market average56.56% below the market average56.56% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.81% below the market average87.81% below the market average87.81% below the market average87.81% below the market average87.81% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Operating Profit Loss
70.4% below the market average70.4% below the market average70.4% below the market average70.4% below the market average70.4% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
64.97% below the market average64.97% below the market average64.97% below the market average64.97% below the market average64.97% below the market average
28.89% below the sector average28.89% below the sector average28.89% below the sector average28.89% below the sector average28.89% below the sector average
Cash
42.6% below the market average42.6% below the market average42.6% below the market average42.6% below the market average42.6% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.28p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 212,860
Shares Issued 2,148.96m
Market Cap £5.91m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.02% below the market average46.02% below the market average46.02% below the market average46.02% below the market average46.02% below the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Price Trend
92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average
Income Not Available
Growth
15.76% below the market average15.76% below the market average15.76% below the market average15.76% below the market average15.76% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average

Theracryf Dividends

No dividends found

Trades for 02-Jun-2025

Time Volume / Share Price
08:29 212,860 @ 0.25p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page